scispace - formally typeset
J

Joanne M. Meyer

Researcher at Novartis

Publications -  108
Citations -  14020

Joanne M. Meyer is an academic researcher from Novartis. The author has contributed to research in topics: Twin study & Population. The author has an hindex of 53, co-authored 108 publications receiving 13590 citations. Previous affiliations of Joanne M. Meyer include Millennium Pharmaceuticals & VCU Medical Center.

Papers
More filters
Patent

Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia

TL;DR: In this paper, a method and compositions for diagnosing and treating neuropsychiatric disorders, such as schizophrenia, schizoaffective disorder, bipolar affective disorder, unipolar affective disorders and adolescent conduct disorder, are presented.
Journal ArticleDOI

Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development.

TL;DR: Genetic factors explained a significant proportion of the variation in the use of tobacco, alcohol and other drugs and shared environmental factors contributed significantly to lifetime alcohol use and other drug use.
Journal ArticleDOI

Assortative mating for major psychiatric diagnoses in two population-based samples

TL;DR: Significant but moderate primary assortment exists for psychiatric disorders and the bias in twin studies that have ignored the small amount of assortment is negligible.
Journal ArticleDOI

Replication of 1q42 linkage in Finnish schizophrenia pedigrees

TL;DR: This paper found evidence for linkage on 1q42 maximizing within the DISC1 gene (rs1000731, lod=2.70), which has also been implied in the etiology of schizophrenia based on functional studies.
Journal ArticleDOI

Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q

TL;DR: Data is reported from a third genome scan in a nationwide Finnish schizophrenia study sample of 238 pedigrees with 591 affected individuals, where some evidence for linkage emerged at 4q, 9q and Xp, the regions also suggested by the previous genome scans, whereas, in the nationwide study sample, the region at 7q failed to show further evidence of linkage.